BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/11/2026 9:15:06 AM | Browse: 11 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 120427
Country China
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Methionine depletion inhibits hepatocellular carcinoma by inducing ferroptosis and suppressing epithelial-mesenchymal transition through the ARNT2/UBE2Z pathway
Manuscript Source Unsolicited Manuscript
All Author List Dong-Dong Yin, Wei-Yu Jiang, Yu-Ting Huang, Shu-Ping Zhou and Yin-Ci Zhang
Funding Agency and Grant Number
Funding Agency Grant Number
Health Research Program of Anhui No. AHWJ2023A30019
Clinical and Translational Research Project of Anhui Province No. 202527c10020090 and No. 202304295107020036
University-Industry Collaborative Education Program No. 230907010211931
Corresponding Author Yin-Ci Zhang, The First Hospital, Anhui University of Science and Technology, No.203 Huaibin Road, Tianjia'an District, Huainan 232000, Anhui Province, China. 13345543605@163.com
Key Words Methionine; Hepatocellular carcinoma; Epithelial-mesenchymal transition; Ferroptosis; ARNT2; UBE2Z
Core Tip Aberrant methionine (Met) metabolism critically promotes the progression of hepatocellular carcinoma (HCC). Met deficiency may induce ferroptosis and inhibit epithelial-mesenchymal transition through the ARNT2/UBE2Z axis, thereby suppressing HCC progression, whereas Met supplementation reverses these effects. Furthermore, high expression levels of ARNT2 and UBE2Z predict unfavorable prognosis in HCC patients. Collectively, these findings indicate that the Met-ARNT2/UBE2Z pathway may serve as a novel anti-HCC therapeutic target.
Citation Yin DD, Jiang WY, Huang YT, Zhou SP, Zhang YC. Methionine depletion inhibits hepatocellular carcinoma by inducing ferroptosis and suppressing epithelial-mesenchymal transition through the ARNT2/UBE2Z pathway. World J Hepatol 2026; In press
Received
2026-02-27 03:14
Peer-Review Started
2026-02-27 03:14
First Decision by Editorial Office Director
2026-03-20 11:18
Return for Revision
2026-03-21 03:10
Revised
2026-04-04 15:15
Publication Fee Transferred
2026-04-05 07:49
Second Decision by Editor
2026-05-11 02:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-05-11 09:15
Articles in Press
2026-05-11 09:15
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com